Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational studyHarrys A. Torres, Anna S. Lok, Jeff Hosry et al.|Hepatology|2017Cited by 121
Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatmentHarrys A. Torres, Ahmed O. Kaseb, Jean‐Nicolas Vauthey et al.|Journal of Hepatology|2016Cited by 79
Antiviral therapy improves overall survival in hepatitis C virus‐infected patients who develop diffuse large B‐cell lymphomaJeff Hosry, Harrys A. Torres, Parag Mahale et al.|International Journal of Cancer|2016Cited by 57
Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancerMinas P. Economides, Harrys A. Torres, Hagop M. Kantarjian et al.|Alimentary Pharmacology & Therapeutics|2016Cited by 51
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational StudyHarrys A. Torres, Bruno Granwehr, Minas P. Economides et al.|The American Journal of Gastroenterology|2018Cited by 20